|
2014
|
Invention
|
Aryloxy amine compounds and their use as sodium channel modulators.
The present invention relate... |
|
2013
|
Invention
|
Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof.
The present invention relat... |
|
2012
|
Invention
|
Compositions and methods for the treatment of fibrosis and fibrotic diseases. The present inventi... |
|
|
Invention
|
Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof. The present invention relate... |
|
|
Invention
|
Tam receptor ligands, metabolites and precursors thereof in the detection and modulation of infla... |
|
|
Invention
|
A method and apparatus for mixing microliter fluid volumes by application of acoustic signals. Th... |
|
2011
|
Invention
|
Single chain relaxin polypeptides. The present invention relates to biologically active single ch... |
|
|
Invention
|
Modified relaxin polypeptides.
The present invention relates to biologically active relaxin poly... |
|
|
Invention
|
Modified relaxin polypeptides. The present invention relates to biologically active relaxin polyp... |
|
|
Invention
|
Treatments for substance abuse and addiction. The present invention relates to methods for the pr... |
|
|
Invention
|
Tam receptors and tam receptor ligands in detection and modulation of neuropathological disease. ... |
|
2010
|
Invention
|
Use of galanin in a method of treating neurodegenerative diseases or conditions.
The present inv... |
|
2009
|
Invention
|
Therapeutic applications. The specification relates to methods for treating a neurodegenerative d... |
|
|
Invention
|
Modulation of an ion channel or receptor.
This invention relates to a method of assaying a compo... |
|
|
Invention
|
Modulation of an ion channel or receptor. This invention relates to a method of assaying a compou... |
|
|
Invention
|
Therapeutic methods and compositions. The present invention is generally directed to the field of... |
|
2008
|
Invention
|
Aryloxy amine compounds and their use as sodium channel modulators. The present invention relates... |
|
|
Invention
|
Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family p... |
|
|
Invention
|
Use of galanin in a method of treating neurodegenerative diseases or conditions. The present inve... |
|
2007
|
Invention
|
Novel compounds and uses thereof. The present invention relates to inhibitors of insulin-regulate... |
|
|
Invention
|
A display system. A display system, including one or more display modules configured to generate ... |
|
|
Invention
|
Method for treatment of anxiety. Human H3 preprorelaxin, human H3 prorelaxin, human H3 relaxin, h... |
|
2006
|
Invention
|
Method of treatment.
The present invention relates generally to a method of treatment and in par... |
|
|
Invention
|
A method of treatment. The present invention relates generally to a method of treatment and in pa... |
|
|
Invention
|
Prophylactic and therapeutic agents and uses therefor.
Treatment, detection and monitoring of di... |
|
|
Invention
|
Prophylactic and therapeutic agents and uses therefor. Treatment, detection and monitoring of dis... |
|
|
Invention
|
Flavonoid compounds and uses thereof. Novel flavonoid compounds having anti-oxidant activity are ... |
|
2005
|
Invention
|
Enzyme inhibitors and uses thereof.
The present invention relates to inhibitors of insulin-regul... |
|
|
Invention
|
Enzyme inhibitors and uses thereof. The present invention relates to inhibitors of insulin-regula... |
|
|
Invention
|
Prevention of fibrosis following cardiac injury.
A method for treating cardiac fibrosis resultin... |
|
2004
|
Invention
|
Relaxin superfamily peptide analogues.
Monomeric, cyclic peptide analogues of relaxin superfamil... |
|
|
Invention
|
Relaxin superfamily peptide analogues. Monomeric, cyclic peptide analogues of relaxin superfamily... |
